Oral candidiasis secondary to adverse anticholinergic effects of psychotropic medications.
Stevens
Hanna E
HE
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001590:Benztropine / Q000009:adverse effects* / Q000627:therapeutic use; D002180:Candidiasis, Oral / Q000139:chemically induced*; D002648:Child; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006801:Humans; D008297:Male; D018727:Muscarinic Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D018967:Risperidone / Q000009:adverse effects* / Q000627:therapeutic use; D013313:Stress Disorders, Post-Traumatic / Q000188:drug therapy* / Q000523:psychology; D014987:Xerostomia / Q000139:chemically induced / Q000150:complications
D014150:Antipsychotic Agents; D018727:Muscarinic Antagonists; D001590:Benztropine; D018967:Risperidone